Header Logo

Connection

KWABENA SARPONG to Measles

Back to Details
This is a "connection" page, showing publications KWABENA SARPONG has written about Measles.
KWABENA SARPONG
Connection Strength
0.040
Measles
  1. Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):194-201.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.